Acupuncture during IVF improves pregnancy chances

Acupuncture given within one day of IVF with embryo transfer improves rates of pregnancy and live birth among women undergoing in vitro fertilisation cycle (IVF), revealed by US researchers. – Acupuncture given with embryo transfer improves rates of pregnancy and live birth among women undergoing in vitro fertilisation cycle (IVF), revealed by US researchers. Acupuncture given within one day of IVF proved beneficial.

Intensive blood glucose lowering treatment proved fatal for diabetes patients

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, USA has stopped one treatment within a large, ongoing North American clinical trial of diabetes and cardiovascular disease 18 months early due to safety concerns after review of available data, although the study will continue. – Intensive blood glucose lowering treatment proved fatal for diabetes patients in a US study, and for Safety, National Heart, Lung, and Blood Institute (NHLBI) has changed intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease.

Breastfeeding safer for infants of HIV mothers with Nevirapine

First solid evidence that viral transmission through breast milk can be prevented by a drug Nevirapine HIV drug. – An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.

27% lower mortality in top hospitals, finds HealthGrades

Hospital quality gap persists, resulting in 171,424 preventable deaths, according to HealthGrades’ Sixth Annual Hospital Quality and Clinical Excellence study. – Patients treated at top-rated hospitals in US are nearly one-third less likely to die, on average, than those admitted to all other hospitals, according to a study released by HealthGrades (Nasdaq: HGRD), the leading independent healthcare ratings organization.

Epilepsy drugs may raise suicide risk, warns FDA

The U.S. Food and Drug Administration today issued new information to health care professionals to alert them about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. – An increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions, reported by U.S. Food and Drug Administration (FDA).

Study examines effectiveness of antiviral drug to treat mononucleosis

University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. – University of Minnesota researchers have begun studying a new drug to treat infectious mononucleosis, commonly known as mono. The goal of the study is to find out if people who take the antiviral drug valomaciclovir recover from mono faster.

Ongoing review of cholesterol drug Vytorin

FDA issues early communication about an ongoing review of vytorin, and advises patients to talk with their health care providers if they have questions about the ENHANCE study. – The U.S. Food and Drug Administration (FDA) is informing the public that the agency will conduct a review of Merck and Schering Plough’s recent trial once the FDA receives the final study results.

Climate change a threat to human health

Climate change will have potentially devastating consequences for human health, outweighing global economic impacts, researchers calling for urgent action to protect the world’s population. – Climate change will have a huge impact on human health and bold environmental policy decisions are needed now to protect the world’s population, according to the author of an article published in the British Medical Journal (BMJ).

Vytorin does not appear to be unsafe – American Heart Association

Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements in The New York Times after a failed study generated negative publicity. – Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. There were no statistically significant differences in the safety of the drugs, which are used to lower cholesterol.

Saline nasal wash improves cold symptoms

A saline nasal wash solution made from processed seawater appears to improve nasal symptoms and may help prevent the recurrence of respiratory infections when used by children with the common cold. – Children show faster resolution of some nasal symptoms during acute illness and less frequent reappearance of rhinitis subsequently, after nasal isotonic saline application to prevent reappearance of cold and flu in children during the winter.

Health Newstrack